| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |